Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Non-cash Items (2016 - 2025)

Historic Non-cash Items for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $7.7 million.

  • Regenxbio's Non-cash Items rose 135425.33% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 135425.33%. This contributed to the annual value of $6.8 million for FY2024, which is 1095.42% up from last year.
  • Per Regenxbio's latest filing, its Non-cash Items stood at $7.7 million for Q3 2025, which was up 135425.33% from $7.3 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Non-cash Items ranged from a high of $74.1 million in Q3 2021 and a low of $529000.0 during Q3 2024
  • For the 5-year period, Regenxbio's Non-cash Items averaged around $12.8 million, with its median value being $7.0 million (2023).
  • Per our database at Business Quant, Regenxbio's Non-cash Items plummeted by 9314.55% in 2022 and then soared by 135425.33% in 2025.
  • Regenxbio's Non-cash Items (Quarter) stood at $41.1 million in 2021, then crashed by 61.62% to $15.8 million in 2022, then crashed by 55.58% to $7.0 million in 2023, then decreased by 2.48% to $6.8 million in 2024, then rose by 12.52% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q3 2025, $7.3 million for Q2 2025, and $7.4 million during Q1 2025.